To address the crosstalk between RIPK3-mediated necroptosis and other PCD mechanisms, researchers have proposed that RIPK3 can be delivered to tumor cells using engineered adeno-associated viruses (AAVs) to induce necroptosis precisely. Here, RIPK3 is linked to neoplasm.